Bone Morphogenetic Proteins: Indications and Uses

Clinics in Podiatric Medicine and Surgery

Volumn 32, Issue 1, 2015, Pages 35-43

  Bibbo, Christopher ^a,b   Nelson, Jonas ^b   Ehrlich, David ^c   Rougeux, Brian ^a  

^a MARSHFIELD CLINIC   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

BMP; Bone healing; Bone morphogenetic protein; Foot and ankle surgery

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; BONE MORPHOGENETIC PROTEINS;

ARTHRODESIS; BONE TRANSPLANTATION; DOWNSTREAM PROCESSING; DRUG APPROVAL; DRUG EFFICACY; FOOT SURGERY; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; NONHUMAN; POSTOPERATIVE COMPLICATION; RECEPTOR BINDING; REVIEW; SURGICAL INFECTION; SURGICAL TECHNIQUE; BONE REGENERATION; FOOT BONES; HUMANS; SURGERY;

ARTHRODESIS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; FOOT BONES; FRACTURE HEALING; HUMANS;

EID: 84922721030     PISSN: 08918422     EISSN: 15582302     Source Type: Journal    
DOI: 10.1016/j.cpm.2014.09.005     Document Type: Review

References (29)

1. Einhorn T.A. Enhancement of fracture-healing. JBone Joint Surg Am 1995, 77:940-956.
2. Bibbo C., Anderson R.B., Davis W.H. Complications of midfoot and hindfoot arthrodesis. Clin Orthop Relat Res 2001, 391:45-58.
3. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
4. Wozney J.M., Rosen V., Celeste A.J., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
5. Marsell R., Einhorn T.A. The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury 2009, 40(Suppl 3):S4-S7.
6. Sharov A.A., Sharova T.Y., Mardaryev A.N., et al. Bone morphogenetic protein signaling regulates the size of hair follicles and modulates the expression of cell cycle-associated genes. Proc Natl Acad Sci USA 2006, 103:18166-18171.
7. Yoshino O., McMahon H.E., Sharma S., et al. Aunique preovulatory expression pattern plays a key role in the physiological functions of BMP-15 in the mouse. Proc Natl Acad Sci USA 2006, 103:10678-10683.
8. Taha M.F., Valojerdi M.R., Mowla S.J. Effect of bone morphogenetic protein-4 (BMP-4) on cardiomyocyte differentiation from mouse embryonic stem cell. Int J Cardiol 2007, 120:92-101.
9. Wang Y.X., Qian L.X., Liu D., et al. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 2007, 74:290-303.
10. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
11. Cheng H., Jiang W., Phillips F.M., et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). JBone Joint Surg Am 2003, 85A:1544-1552.
12. Ryoo H.M., Lee M.H., Kim Y.J. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 2006, 366:51-57.
13. Nohe A., Keating E., Knaus P., et al. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004, 16:291-299.
14. Groppe J., Greenwald J., Wiater E., et al. Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cysteine knot protein. JBone Joint Surg Am 2003, 85A(Suppl 3):52-58.
15. Zhao M., Qiao M., Harris S.E., et al. Smurf1 inhibits osteoblast differentiation and bone formation invitro and invivo. JBiol Chem 2004, 279:12854-12859.
16. Zhao M., Qiao M., Oyajobi B.O., et al. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. JBiol Chem 2003, 278:27939-27944.
17. Zhu H., Kavsak P., Abdollah S., et al. ASMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 1999, 400:687-693.
18. Shen R., Chen M., Wang Y.J., et al. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. JBiol Chem 2006, 281:3569-3576.
19. Kaneki H., Guo R., Chen D., et al. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. JBiol Chem 2006, 281:4326-4333.
20. Singhatanadgit W., Salih V., Olsen I. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells. Int J Biochem Cell Biol 2006, 38:1794-1807.
21. Bouxsein M.L., Turek T.J., Blake C.A., et al. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. JBone Joint Surg Am 2001, 83A:1219-1230.
22. Gerhart T.N., Kirker-Head C.A., Kriz M.J., et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Relat Res 1993, 293:317-326.
23. Bibbo C., Haskell M.D. Recombinant bone morphogenetic protein-2 (rhBMP-2) in high-risk foot & ankle surgery: techniques & preliminary results of a prospective, intention to treat study. Tech Foot Ankle Surg 2007, 6:71-79.
24. Bibbo C., Patel D.V., Haskell M.D. Recombinant bone morphogenetic protein-2 (rhBMP-2) in high-risk ankle and hindfoot fusions. Foot Ankle Int 2009, 30:597-603.
25. Mesfin A., Buchowski J.M., Zebala L.P., et al. High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases. JBone Joint Surg Am 2013, 95:1546-1553.
26. Carragee E.J., Chu G., Rohatgi R., et al. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. JBone Joint Surg Am 2013, 95:1537-1545.
27. Cooper G.S., Kou T.D. Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2). Spine (Phila Pa 1976) 2013, 38:1862-1868.
28. Veeravagu A., Cole T., Jiang B., et al. The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the Marketscan Longitudinal Database. Spine J 2014, pii:S1529-9430(14)00472-0. 10.1016/j.spinee.2014.05.010.
29. Lad S.P., Bagley J.H., Karikari I.O., et al. Cancer after spinal fusion: the role of bone morphogenetic protein. Neurosurgery 2013, 73:440-449.